Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Providence Medical Technology Receives FDA 510(k) Clearance for CORUS™ PCSS 3D-T ...

13 October 2026 · By · Wire by Fusion42

Published

13 October 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at prnewswire.com →

◆ Verified

Fusion42 · 13 October 2026 · Fusion42 review

Providence Medical Technology received FDA 510(k) clearance for its CORUS™ PCSS 3D-T implant, a next-generation posterior cervical fusion device featuring 3D-printed porous titanium to support bone ingrowth while retaining the established surgical technique.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You can now access a spinal fusion implant that improves bone integration with 3D-printed titanium while using familiar surgical techniques, opening a faster path to surgeon adoption and better patient outcomes.

◆ Coverage

1 source · 13 Oct 2026

◆ Related on Wire

◆ Topics

Medtechfda-clearancemedical-device3d-printingspine-surgeryimplant-technology